Century Therapeutics Inc(IPSC:US)

Market Cap$246.74M

Key Metrics

Price$1.37

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$107.78M

EBITDA (TTM)-$88.71M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$51.05M

Total Assets$326.55M

Net Assets$264.74M

Total Debt$48.03M

Century Therapeutics Inc(IPSC:US)

Market Cap$246.74M

Price history

Key Metrics

Price$1.37

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$107.78M

EBITDA (TTM)-$88.71M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$51.05M

Total Assets$326.55M

Net Assets$264.74M

Total Debt$48.03M

Financials

NameMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Revenue
$0$0$0$0$109.16M$4.17M$791K$771K$855K$268K$148K$99K$1.72M$521K$2.22M$1.4M$1.06M$0$0$0$0$0$0$0$0
Cost of Revenue
-------------------------
Gross Profit
-------------------------
$23.68M$20.65M$29.36M$34.66M-------$30.96M$33.8M$33.83M$33.96M$32.75M$28.49M$27.97M$25.83M$23.02M$18.06M$15.26M$13.13M$10.79M$9.99M
Research and Development$17.11M$19.7M$22.53M$26.86M-------$22.73M$24.9M$25.59M$25.9M$24.49M$21.2M$21.8M$19.55M$18.93M$15.37M$12.44M$10.81M$8.48M$7.94M
Selling, General, and Administrative$6.58M$956K$6.84M$7.81M-------$8.23M$8.9M$8.24M$8.06M$8.25M$7.3M$6.18M$6.28M$4.09M$2.69M$2.82M$2.32M$2.31M$2.05M
Other Operating Expenses-------------------------
Operating Income
-$23.68M-$20.65M-$29.36M-$34.66M--------$30.86M-$32.08M-$33.31M-$31.74M-$31.35M-$27.44M-$27.97M-$25.83M-$23.02M-$18.06M-$15.26M-$13.13M-$10.79M-$9.99M
$2.04M$1.41M-$5.06M$2.12M--------$1.48M$2.08M$1.75M$1.09M$457K-$9.99M-$244K$35K-$176K-$183K$368K$75K-$4.51M$640K
Non-Operating Interest Income$2.02M$1.31M$1.61M$2.01M-------$3.06M$2.62M-$1.41M$706K$253K-$140K$66K$28K-$120K$215K$320K
Non-Operating Interest Expense-----------$136K$348K$318K$296K$254K$238K$244K$245K$242K$239K$336K$45K$0$0
Other Income/Expense$20K$103K-$6.67M$113K--------$4.41M-$194K$2.07M-$24K$5K-$10M-$140K-$28K$704K--$4.72M$320K
Income Before Tax
-$21.65M-$19.24M-$34.42M-$32.54M--------$32.34M-$30.06M-$31.65M-$30.72M-$30.97M-$37.5M-$28.15M-$26.01M-$23.27M-$18.35M-$15.53M-$13.07M-$15.3M-$9.67M
Income Tax
--$68K$0$0-------$950K$1.21M$32K$25K$18K$16K-$0$0$0----
Net Income
-$21.65M-$19.17M-$34.42M-$32.54M--------$33.29M-$31.26M-$31.68M-$30.75M-$30.99M-$37.51M-$28.19M-$26.01M-$23.27M-$18.35M-$15.53M-$13.07M-$15.3M-$9.67M
Minority Interests
-------------------------
Preferred Stock Dividends
-------------------------
Net Income to Common
-$21.65M-$19.17M-$34.42M-$32.54M--------$33.29M-$31.26M-$31.68M-$30.75M-$30.99M-$37.51M-$28.19M-$26.01M-$23.27M-$18.35M-$15.53M-$13.07M-$15.3M-$9.67M
Shares Outstanding (Basic)
193.47M-86.46M86.24M86.02M-84.7M82.09M62.3M-59.45M59.25M58.61M-57.97M57.69M57.05M-54.47M54.4M54.82M-41.8M41.8M41.8M
Shares Outstanding (Diluted)
193.47M-86.46M86.24M86.1M-84.7M82.09M62.3M-59.45M59.25M58.61M-57.97M57.69M57.05M-54.47M54.4M54.82M-41.8M41.8M41.8M
EPS (Basic)
-$0.11--$0.40-$0.38$0.89--$0.37-$0.38-$0.45--$0.55-$0.56-$0.53--$0.53-$0.54-$0.66--$0.48-$0.43-$0.33--$0.31-$0.37-$0.23
EPS (Diluted)
-$0.11--$0.40-$0.38$0.89--$0.37-$0.38-$0.45--$0.55-$0.56-$0.53--$0.53-$0.54-$0.66--$0.48-$0.43-$0.33--$0.31-$0.37-$0.23
EBIT
-$23.68M-$20.65M-$29.36M-$34.66M--------$32.21M-$29.71M-$31.33M-$30.43M-$30.72M-$37.26M-$27.91M-$25.76M-$23.03M-$18.11M-$15.2M-$13.03M-$15.3M-$9.67M
EBITDA
-$20.68M-$17.1M-$19.47M-$31.46M--------$24.75M-$26.8M-$28.49M-$27.65M-$29.05M-$26.1M-$26.86M-$24.72M-$22.1M-$17.39M-$14.69M-$12.62M-$10.3M-$9.47M